兆科眼科-B 宣布,其药物 Yuvezzitm 已获准在海南博鳌超级医院作为临床急需进口药物投入临床使用。此举标志着该产品在满足特定临床需求方面取得了重要进展。
兆科眼科-B 宣布,其药物 Yuvezzitm 已获准在海南博鳌超级医院作为临床急需进口药物投入临床使用。此举标志着该产品在满足特定临床需求方面取得了重要进展。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.